David L. Eisenberg, MD, MPH, FACOG
David J. Portman, MD
A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator
Lee P. Shulman, MD, FACMG, FACOG
Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability
Andrew M. Kaunitz, MD, FACOG
New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)
Anita L. Nelson, MD
The Evolution of Estrogen in Contraception—From E1 to E4
Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch
The Changing Landscape of Contraceptive Trials: Recent Approvals and Future Directions
The Changing Landscape of Contraceptive Trials: Recent Approvals and Future D...
William Mencia, MD, FACEHP, CHCP
Stephen M. Cohen, MD, FACOG
New Directions in the Management of Uterine Fibroids
The Creeping Pearl Index: Distinguishing Between Clinical Trial Efficacy and ...
Thomas D. Kimble, MD
Expanding Choices in Combined Hormonal Contraceptives: The Creeping Pearl Index
Kenneth J. Moise Jr., MD
Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagnosis and Management
Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagn...
A New Era Begins in Contraception: The Vaginal Gel pH Modulator
Health Disparities in the Management of Uterine Fibroids
Expanding Choices in Combined Hormonal Contraceptives—Seeing Beyond LARCs
Expanding Contraceptive Choices Beyond Long-Acting Reversible Methods
Viewing Contraceptive Efficacy/Effectiveness Through a New Lens
Stay current with the best on medical education
We’re glad to see you’re enjoying Omnia Education…but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.